A Glycolipid α-GalCer Derivative, 7DW8-5 as a Novel Mucosal Adjuvant for the Split Inactivated Influenza Vaccine

Influenza virus infects the host and transmits through the respiratory tract (i.e., the mouth and nose); therefore, the development of intranasal influenza vaccines that mimic the natural infection, coupled with an efficient mucosal adjuvant, is an attractive alternative to current parenteral vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Huapeng, Sun, Ruolin, Song, Guanru, Zhu, Shunfan, Nie, Zhenyu, Lin, Liming, Yi, Ruonan, Wu, Shixiang, Wang, Genzhu, He, Yulong, Wang, Siquan, Wang, Pei, Wu, Li, Shu, Jianhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230830/
https://www.ncbi.nlm.nih.gov/pubmed/35746644
http://dx.doi.org/10.3390/v14061174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230830/
https://www.ncbi.nlm.nih.gov/pubmed/35746644
http://dx.doi.org/10.3390/v14061174

Ejemplares similares